Perinatal antibiotic exposure of neonates in Canada and associated risk factors: a population-based study

References

• Health Indicators Interactive Tool [Internet]. Ottawa, ON: Canadian Institute for Health Research; 2011. Available from: http://www.cihi.ca/hirpt/search.jspa [last accessed 27 May 2014]
   Google Scholar
• Johri AK, Paoletti LC, Glaser P, et al. Group B Streptococcus: global incidence and vaccine development. Nat Rev Microbiol 2006;4:932–42
   PubMed Web of Science ®Google Scholar
• Schalkwyk J, Eyk N. Antibiotic prophylaxis in obstetric procedures. J Obstet Gynaecol Canada 2010;32:878–92
   PubMedGoogle Scholar
• Heaman M, Kingston D, Helewa ME, et al. Perinatal services and outcomes in Manitoba. Winnipeg, MB: Manitoba Centre for Health Policy; November 2012
   Google Scholar
• Money DM, Dobson S. The prevention of early-onset neonatal group B streptococcal disease. J Obstet Gynaecol Canada 2004;26:826–40
   PubMedGoogle Scholar
• Konrad G, Hauch S, Pylypjuk C. Prevention of neonatal group B streptococcal infection: approaches of physicians in Winnipeg, Man. Can Fam Physician 2007;53:290, 289:e.1–5, 289
   Google Scholar
• Flenady V, King J. Antibiotics for prelabour rupture of membranes at or near term. Cochrane Database Syst Rev 2002;(3):CD001807
   Google Scholar
• Barrington K. Management of the infant at increased risk for sepsis. Paediatr Child Health 2007;12:893–8
   PubMed Web of Science ®Google Scholar
• Penders J, Kummeling I, Thijs C. Infant antibiotic use and wheeze and asthma risk: a systematic review and meta-analysis. Eur Resp J 2011;38:295–302
   PubMed Web of Science ®Google Scholar
• Penders J, Thijs C, Brandt PA, et al. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 2007;56:661–7
   PubMed Web of Science ®Google Scholar
• Fouhy F, Guinane C, Hussey S, et al. High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin. Antimicrob Agents Chemother 2012;56:5811–20
   PubMed Web of Science ®Google Scholar
• Favier CF, de Vos WM, Akkermans ADL. Development of bacterial and bifidobacterial communities in feces of newborn babies. Anaerobe 2003;9:219–29
   PubMed Web of Science ®Google Scholar
• Canadian Guidelines for Body Weight Classification in Adults [Internet]. Ottawa, ON: Health Canada; 2003. Available from: http://www.hc-sc.gc.ca/fn-an/nutrition/weights-poids/guide-ld-adult/bmi_chart_java-graph_imc_java-eng.php [last accessed 27 May 2014]
   Google Scholar
• Bar-Oz B, Bulkowstein M, Benyamini L, et al. Use of antibiotic and analgesic drugs during lactation. Drug Saf 2003;26:925–35
   PubMed Web of Science ®Google Scholar
• Yoshioka H, Cho K, Takimoto M, et al. Transfer of cefazolin into human milk. J Pediatr 1979;94:151–2
   PubMed Web of Science ®Google Scholar
• Charles D. Placental transmission of antibiotics. J Obstet Gynaecol Br Emp 1954;61:750–7
   PubMedGoogle Scholar
• McKeever TM, Lewis SA, Smith C, Hubbard R. The importance of prenatal exposures on the development of allergic disease. Am J Resp Crit Care Med 2002;166:827–32
   PubMed Web of Science ®Google Scholar
• Fairlie T, Zell ER, Schrag S. Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease. Obstet Gynecol 2013;121:570–7
   PubMed Web of Science ®Google Scholar
• Mahieu LM, Dooy JJ, Leys E. Obstetricians’ compliance with CDC guidelines on maternal screening and intrapartum prophylaxis for group B streptococcus. J Obstet Gynaecol 2000;20:460–4
   PubMedGoogle Scholar
• Hughes RG, Brocklehurst P, Heath P, Stenson B. The prevention of early-onset neonatal group B Streptococcal disease. RCOG Green-Top Guideline No. 36. 2nd ed. London: Royal College of Obstetricians and Gynaecologists; 2012:1–13
   Google Scholar
• Stokholm J, Schjørring S, Pedersen L, et al. Prevalence and predictors of antibiotic administration during pregnancy and birth. PloS One 2013;8:e82932
   PubMed Web of Science ®Google Scholar
• Alfirevic Z, Gyte G, Dou L. Different classes of antibiotics given to women routinely for preventing infection at caesarean section (Review). Cochrane Database Syst Rev 2010;6:CD008726
   Google Scholar
• American College of Obstetricians and Gynecologists. Use of prophylactic antibiotics in labor and delivery. Obstet Gynecol 2011;117:1472–83
   PubMedGoogle Scholar
• Doss AE, Davidson JD, Cliver SP, et al. Antibiotic prophylaxis for cesarean delivery: survey of maternal-fetal medicine physicians in the U.S. J Matern Fetal Neonatal Med 2012;25:1264–6
   PubMed Web of Science ®Google Scholar
• Raghunathan K, Connelly NR, Friderici J, et al. Unwarranted variability in antibiotic prophylaxis for cesarean section delivery: a national survey of anesthesiologists. Anesth Analg 2013;116:644–8
   PubMed Web of Science ®Google Scholar
• Alm B, Erdes L, Möllborg P, et al. Neonatal antibiotic treatment is a risk factor for early wheezing. Pediatrics 2008;121:697–702
   PubMed Web of Science ®Google Scholar
• Trasande L, Blustein J, Liu M, et al. Infant antibiotic exposures and early-life body mass. Int J Obes 2013;37:16–23
   PubMed Web of Science ®Google Scholar
• Ajslev TA, Andersen CS, Gamborg M, et al. Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibiotics. Int J Obes (Lond) 2011;35:522–9
   PubMed Web of Science ®Google Scholar
• Minassian C, Thomas SL, Williams DJ, et al. Acute maternal infection and risk of pre-eclampsia: a population-based case-control study. PLoS One 2013;8:e73047
   Google Scholar
• Sebastián Manzanares G, Angel Santalla H, Irene Vico Z, et al. Abnormal maternal body mass index and obstetric and neonatal outcome. J Matern Fetal Neonatal Med 2012;25:308–12
   PubMed Web of Science ®Google Scholar